Pages that link to "Q48245366"

The following pages link to A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model (Q48245366):

Displaying 11 items.

• The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders (Q41661210) (← links)
• RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes (Q47769365) (← links)
• Gut hormone polyagonists for the treatment of type 2 diabetes (Q49218095) (← links)
• Effect of Chinese herbal compound GAPT on the early brain glucose metabolism of APP/PS1 transgenic mice (Q64069036) (← links)
• Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease (Q64092659) (← links)
• Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes (Q89113530) (← links)
• Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions (Q89940067) (← links)
• Glucagon-like peptide-2 rescues memory impairments and neuropathological changes in a mouse model of dementia induced by the intracerebroventricular administration of streptozotocin (Q90241821) (← links)
• A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice (Q91440655) (← links)
• The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD (Q92792434) (← links)
• Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury (Q93054879) (← links)